Greetings Money Makers! I have quite the Investment play for you tonight. I've been following this company for quite some time, and due to a recent development, I feel now is the time to encourage you to research DNDT - DND Technologies. I believe DNDT is the perfect Mid to Long Term Investment for a number of reasons. DNDT is a fully Reporting company with a freely tradeable float of only 6.5 Million. They increased Revenues and Profits last quarter by over 190%. In FACT, they are 100% PROFITABLE. They haven't increased their share structure in 2012, actually Reducing the AS by 1.2 Billion shares. But the biggest part of this story, is that is just the beginning. DNDT currently trades at $0.013.
DND Technologies a diversified holding company that acquires, invests in, and partners with next generation start-ups and established businesses to bring new or improved products to market, is negotiating new investments and appointments. Recently, on Monday, they released a shareholder update, not to the market, but to their current shareholders. It states: Dear Shareholders:
"I am pleased to give you a brief, overdue update on the company’s activities as it seek to build itself and increase long-term, enhanced shareholder value. Having made the necessary filings to bring the company fully “Pink” on the OTC a few months ago, management has been very busy with activities it believes are designed to increase shareholder value. Shareholders may have noticed that, as an initial step, the company lowered the authorized shares from two billion to 800 million on the OTC. (Nevada filings will be completed shortly).
Over the past several months, management has been negotiating to acquire equity interest in several technology projects. Among them: a European mobile payments company that may be entering the U.S. market later this year, and a telecom and information technology company that offers a wide array of IT services, has an MVNO (mobile telephony using a major carrier’s network), and has recently submitted an application for a second such license. The company expects to reach final agreements on these and other technology projects very shortly.
DNDT’s wholly-owned, manufacturing subsidiary, mmstockplay.us4.list-manage1.com/track/click?u=c49e34c2c3988c7c8d3c99016&id=01f2ea9aa0&e=2a787d531f is in current discussions with a view to appointing manufacturer’s representatives in several countries to introduce and sell its product line to wholesalers and retailers, and intends to broadening of its product line, especially for the European market.
The Board has endorsed a recommendation aimed at providing shareholders with frequent, information regarding these and other projects as we proceed forward. As a result, an investor relations firm will be appointed shortly."
What I enjoyed in reading this was a few things. The AS reduction, even though any shares they sell are restricted and current restricted shares aren't due to be free until 2014. Second, they are VERY CLOSE to reaching final agreements on 2 HUGE acquisitions. Based on their past acquisition, Best Balms, the fastest growing Balm Company in the WORLD, I expect these to be huge Acquisitions, with already profitable companies, much like Best Balms. Also, Best Balms is adding 2 additional Patent pending products, as well as looking to relocate their Distribution Center. Also, as mentioned in the Email to subscribers, Best Balms is looking to Introduce and sell their products to wholesalers and retailers. Currently, they sell solely online, and still have managed to be the 3rd largest Natural Balm Supplier in the World, and again, the Fastest Growing one. Now another HUGE development, dcrrently, the FDA puts out a list of approved companies that FDA employees are allowed to INVEST in. Employees are not allowed to invest in companies not on the list because they have a conflicting interest, and may be privy to Insider information working for the FDA. Basically, to make the list, a company may not have 10% or more of it’s annual sales on FDA regulated product, OR they may not sell product that is sold solely in FDA regulated fields. DNDT is NOT on the list. So they are either selling FDA approved product, OR they are in the process of gaining FDA approval on their product. In addition, DNDT was on the list in March of 2011, they are no longer. FDA employees are now privy to INSIDER info on DNDT in my opinion.
Moving Foward - I expect several updates from the company, and a PPS push, as they are in discussions with an IR firm. I HAVE accumulated stock here, and am ready for DNDT to make a run, much, much higher than it's current levels. At $0.0130 cents, DNDT is a 5 out of 5 Star Investment IMO.
AI
